In the News
Genome Sequence of E. coli O104:H4 Leads to Rapid Development of a Targeted Antimicrobial Agent against This Emerging Pathogen
Rapid Generation of Targeted Antibacterial Agents in Response to Serious Food Safety Pathogens Detailed by AvidBiotics in PLoS ONE
DGR Technology Platform for Engineering Proteins Advanced in Publication by AvidBiotics Collaborators
AvidBiotics’ Targeted Antibacterial Proteins Show Potential to Address Food-Borne Bacterial Infections, Provide Antibiotic Alternative
One-on-One with Jim Knighton of AvidBiotics
An Escherichia coli O157-Specific Engineered Pyocin Prevents and Ameliorates Infection by E. coli O157:H7 in an Animal Model of Diarrheal Disease
Technology
AvidBiotics technology portfolio includes two proprietary product platforms:
Targeted Antibacterial Proteins
Avidocin™ and Purocin™ proteins – non-antibody, antibacterial proteins that are engineered to bind very specifically to targeted bacteria and kill by punching a hole in…
Micacide™ Proteins
Non-antibody proteins that bind to specific targeted molecules on the surface of infected or cancer cells, where they flag the cells for destruction…
Diversigene™
DiversiGene™ Platform (based on Diversity Generating Retroelements or DGR) that enables the highly efficient generation of molecular diversity and is applicable to any protein scaffold…